95.42USD-1.72%Mkt Cap: 18.99B USDP/E: 13.43Last update: 2026-06-01
Incyte Corporation, a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics in the United States, Europe, Canada, and Japan. The company offers JAKAFI for the treatment o…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap18.99B USD
Enterprise Value15.35B USD
Revenue (TTM)5.36B USD
Gross Profit4.77B USD
Net Income (TTM)1.29B USD
Revenue/Share27.27 USD
Last Price95.42 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees2.8K
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS45337C1027
Valuation
P/E (Trailing)13.43
P/E (Forward)10.67
PEG0.36
EV/EBITDA9.91
EV/Revenue2.86
P/S3.61
P/B3.44
EPS (TTM)7.08
EPS (Forward)9.07
52W Range
63.9365% of range112.29
52W High112.29 USD
52W Low63.93 USD
Profitability
Gross Margin92.76%
Oper. Margin25.55%
EBITDA Margin28.89%
Profit Margin25.03%
ROE24.90%
ROA18.49%
Growth
Revenue Growth20.90%
Earnings Growth83.80%
Cash Flow & Leverage
Operating CF1.41B USD
CapEx (TTM)83.87M USD
FCF Margin10.42%
FCF Yield2.94%
Net Debt-3.98B USD
Net Debt/EBITDA-2.57
Balance Sheet
Debt/Equity0.01
Current Ratio3.68
Quick Ratio3.40
Book Value/Sh28.12 USD
Cash/Share20.10 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split2:1
Split DateSep 1, 2000
Analyst Consensus
Rating2.4 (Buy)
Target (Mean)107.96 USD
Target Range71.00 USD – 135.00 USD
# Analysts24
Ownership
Shares Out.199.78M
Float167.82M
Insiders1.89%
Institutions106.50%
Short Interest
Short Ratio7.6d
Short % Float9.52%
Short % Out.5.53%
Shares Short11.04M
Short (prev mo.)11.97M
Technical
SMA 5095.77 (-0.4%)
SMA 20095.63 (-0.2%)
Beta0.80
S&P 52W Chg27.94%
Avg Vol (30d)1.24M
Avg Vol (10d)1.13M
Technical Indicators
RSI (14)50.2
MACD0.1376
MACD Signal0.2243
MACD Hist.-0.0866
BB Upper100.20 USD
BB Middle97.53 USD
BB Lower94.86 USD
BB Width5.47%
ATR (14)2.417 USD
Vol Ratio (20d)0.55x